share_log

Akari Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ray Prudo, M.D.(22.7%),RPC Pharma Limited(7.9%), etc.

SEC announcement ·  Apr 15, 2023 04:06
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.